1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Celyad Oncology SA
  6. News
  7. Official Publications
    CYAD   BE0974260896

CELYAD ONCOLOGY SA

(CYAD)
  Report
Real-time Quote. Real-time Euronext Bruxelles - 05/16 03:00:21 am
1.604 EUR   -2.20%
05/06Celyad Oncology SA Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/05CELYAD ONCOLOGY SA : 1st quarter results
CO
05/05CELYAD ONCOLOGY SA : Proxy Statments
CO
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Official Publications
05/05/22Proxy Statments 
05/05/22Proxy Statments 
05/05/221st quarter results 
05/05/221st quarter results 
04/01/22Ordinary general shareholder meeting 
04/01/22Ordinary general shareholder meeting 
03/24/22SEC Filing 20 F 
03/24/22Annual results 
03/24/22Annual results 
03/24/22Annual Report 
03/24/22Annual Report 
03/24/22Mixed general shareholder meeting 
12/15/21Crossing thresholds 
12/15/21Crossing thresholds 
12/03/21Security operations 
12/03/21Security operations 
11/10/213rd quarter results 
11/10/213rd quarter results 
11/10/21SEC Filing 6K-3 
10/29/21Monthly statement on outstanding equity shares and voting rights 
08/04/21SEC Filing 6K-2 
08/04/21Half-year report 
08/04/21Half-year report 
07/30/21Monthly statement on outstanding equity shares and voting rights 
07/30/21Crossing thresholds 
07/30/21Crossing thresholds 
06/30/21Monthly statement on outstanding equity shares and voting rights 
06/30/21Crossing thresholds 
06/30/21Crossing thresholds 
05/31/21Monthly statement on outstanding equity shares and voting rights 
05/31/21Monthly statement on outstanding equity shares and voting rights 
05/25/21Proxy Statments 
05/19/21Crossing thresholds 
05/19/21Crossing thresholds 
05/07/21SEC Filing 6K-1 
05/06/211st quarter results 
05/06/211st quarter results 
05/05/21Crossing thresholds 
05/05/21Crossing thresholds 
05/05/21Proxy Statments 
05/05/21Proxy Statments 
05/04/21Crossing thresholds 
05/04/21Crossing thresholds 
04/30/21Monthly statement on outstanding equity shares and voting rights 
04/30/21Crossing thresholds 
04/30/21Crossing thresholds 
03/31/21Crossing thresholds 
03/31/21Crossing thresholds 
03/24/21Annual results 
03/24/21Annual Report 
03/24/21Press Release 
03/24/21Annual results 
03/24/21Annual Report 
01/20/21Crossing thresholds 
01/20/21Crossing thresholds 
11/10/203rd quarter earnings 
11/10/203rd quarter earnings 
11/10/203rd quarter earnings 
08/06/20Half-year results 
08/06/20Half-year results 
06/10/20Proxy Statments 
05/07/201st quarter results 
05/07/201st quarter results 
05/07/201st quarter results 
05/05/20Proxy Statments 
05/05/20Proxy Statments 
05/05/20Proxy Statments 
05/05/20Extraordinary general shareholder meeting 
04/03/20Mixed general shareholder meeting 
04/03/20Acquisition 
03/24/20SEC Filing 6K-4 
03/24/20Annual results 
03/24/20Annual results 
03/24/20Annual results 
03/24/20Press Release 
1  2Next
Upcoming event on CELYAD ONCOLOGY SA